Bentham Science Logo
Journal Cover

Track Your Manuscript:

Recent Patents on Anti-Cancer Drug Discovery

Volume 17, 4 Issues, 2022
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery


Volume 17


Number 3

Mini-Review Article

Review Article

Review Article

Research Article

Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer

, 17(3): 297 - 311

Zefeng Wang, Qianfei Cui, Ling Shi, Meiling Zhang, Peng Song*, Dongzhu Duan* and Wenjing Guo*

DOI: 10.2174/1574892817666211224142100

Recent Patents on Anti-Cancer Drug Discovery, Volume 17 (2022) - Number 4

This issue is in progress but contains articles that are final and fully citable.

Abstracts Ahead of Print

Development and Validation of a Hypoxia - Related Prognostic Model for Ovarian Cancer

Linling Xie, Meijun Pan, Zhaoping Zhang, Xiaotao Jiang, Yi Chen, Guantong Liu, Yanfen Chen, Yuhua Zeng, Jieshan Guan*, Ruling Lu and Lei Zeng*

DOI: 10.2174/1574892817666220623154831
View Abstract

Clinical CDK2 Inhibitors: Trends To Selectivity and Efficacy

Polina V. Rusina, Alexey A. Lisov, Alexandra A. Denisova, Erik R. Gandalipov, Fedor N. Novikov* and Alexander A. Shtil

DOI: 10.2174/1574892817666220617091700
View Abstract

ZFP36L1 Promotes Gastric Cancer Progression Via Regulating JNK and p38 MAPK Signaling Pathways

Kang Ding, Fengping Zhang, Gaoxiu Qi, Meng Lin Lin, Min Chen, Yanchun Chen, Jie Zheng and Fenghua Zhou*

DOI: 10.2174/1574892817666220524102403
View Abstract

Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response

Charles L. Wiseman, Alexander Kharazi, Vivekananda G. Sunkari, Jacqueline L. Galeas, Vito Dozio, Hind Hashwah, Eva Macúchová, William V. Williams and Markus D. Lacher*

DOI: 10.2174/1574892817666220518123331
View Abstract

pH-responsive co-loaded sulfated hyaluronic acid nanoparticles for treatment of breast cancer via co-targeting tumor cells and CAFs

Di Wang, Jingliang Wu*, Cuiping Qi, Jinping Dong, Xueying Ding, Guohua Yu, Shuzhen Liu, Bo Zhang, Zhiqin Gao, Xiuhong Wei* and Hongying Liu*

DOI: 10.2174/1574892817666220510123820
View Abstract

Published Contents

Editor's Choice

STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells

, 2021; 16(3): 350 - 362

Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*

DOI: 10.2174/1574892816666210224155403

Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review

, 2021; 16(2): 161 - 186

Zainab Sabry Othman Ahmed, Matthew Golovoy, Yassen Abdullah, Reda Saber Ibrahim Ahmed and Q. Ping Dou*

DOI: 10.2174/1574892816666210615163417

Feasibility of Repurposing Clioquinol for Cancer Therapy

, 2020; 15(1): 14 - 31

Raheel Khan, Harras Khan, Yassen Abdullah and Q. Ping Dou*

DOI: 10.2174/1574892815666200227090259

HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*

DOI: 10.2174/1574892814666190919152001

Open Access Articles

The Application of Nanotechnology in Immunotherapy Based Combinations for Cancer Treatment

, 2022; 17: 1 - 13 (E-Pub Ahead of Print)

Hongxia Li, Qiuxia Fu, Tobias Achu Muluh*, Shafiu A. Umar Shinge, Shaozhi Fu and JingBo Wu

Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review

, 2021; 16(1): 108 - 116

Shuo Li*, Linping Ke*, Xue Meng, Haiyan Zhou, Xiqin Zhang, Huaguo Wu, Jinming Yu* and Hui Zhang*

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

, 2016; 11(2): 184 - 196

Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo

Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*

DOI: 10.2174/1574892814666190514104035

Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*

DOI: 10.2174/1574892814666190102122848

Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito

DOI: 10.2174/1574892814666190111120023

General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*

DOI: 10.2174/1574892814666190919152001

Research Article

A truncated snail1 transcription factor alters the expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line

, 2019; 14(2): 158-169.

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*

DOI: 10.2174/1574892814666190527111429

Review Article

Cucurbitacins as anticancer agents: A patent review

, 2019; 14(2): 133-143.

Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali

DOI: 10.2174/1574892813666181119123035

Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*

DOI: 10.2174/1574892814666190116111827

Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*

DOI: 10.2174/1574892814666190119165157

Review Article (Mini-Review)

Developments in the application of 1,2,3-triazoles in cancer treatment

, 2020; 15(2): 92-112.

Katerina I. Slavova, Lozan T. Todorov*, Nataliya P. Belskaya, Mauricio A. Palafox and Irena P. Kostova

DOI: 10.2174/1574892815666200717164457

Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*

DOI: 10.2174/1574892814666190111104834

Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna

DOI: 10.2174/1574892814666191022163540

General Review Article

Natural product as substrates of abc transporters: A review

, 2021; 16(2): 222-238.

Xuan-Yu Chen, Jing-Quan Wang, Yuqi Yang, Jing Li* and Zhe-Sheng Chen*

DOI: 10.2174/1574892816666210218220943

Review Article (Mini-Review)

Alkaloids as anticancer agents: A review of chinese patents in recent 5 years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*

DOI: 10.2174/1574892815666200131120618

Most Accessed Articles

Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells

, 2021; 16(4): 521-532.

Fuyuan Zhang, Huali Xu, Rui Xia, Ping Yu, Yuangeng Li, Xiaofeng Yu and Dayun Sui*

DOI: 10.2174/1574892816666210607100239

Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review

, 2021; 16(4): 498-520.

Debasmita Mukhopadhyay, Catherine Sano, Nour AlSawaftah, Raafat El-Awady, Ghaleb A. Husseini* and Vinod Paul

DOI: 10.2174/1574892816666210706155110

STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells

, 2021; 16(3): 350-362.

Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*

DOI: 10.2174/1574892816666210224155403

Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification

, 2021; 16(3): 417-425.

Xiaoshuang Wang, Liwei Liu, Qiuzheng Du, Zhi Sun, Erli Yue, Peng Xue* and Hongyu Zhao*

DOI: 10.2174/1574892816666210224160120

BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients

, 2021; 16(3): 445-455.

Temesgen Sisay Hailemariam, Mohammed Mehdi*, Samuel Kinde, Daniel Seifu and Abebe Edao

DOI: 10.2174/1574892816666210222152126

The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking

, 2021; 16(3): 426-435.

Tao Zou, Yuanqiong Huang, Yifan Hu, Mingyu Wu, Yueshui Zhao, Fukuan Du, Mingxing Li, Xu Wu, Huijioa Ji, Parham Jabbarzadeh Kaboli, Shurong Wang, Zhangang Xiao* and Zhigui Wu*

DOI: 10.2174/1574892816666210211143059


Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
View Full Editorial Board

COPE Compliant

Cope Logo



Related Journals

Related eBooks

eBooks Catalog